AMRN vs GS · rev $87.3M vs P/E 20, rev $37.56B
Amarin Corporation PLC (AMRN) versus Goldman Sachs Group Inc (GS) — a side-by-side from cached financials, not a winner call.
Amarin Corporation PLC (AMRN) is a drug manufacturers - general company listed on US.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David Solomon.
Latest reported AMRN revenue for 2026-06-30 was $87.3M. Net income was -$18.2M. Revenue was up 93.5% from 2026-03-31 to 2026-06-30. AMRN currently screens at market cap $292.1M.
Latest reported GS revenue for 2026-06-30 was $37.56B. Net income was $12.26B. GS currently screens at market cap $324.25B and trailing P/E 20.1.
AMRN currently screens at market cap $292.1M. GS currently screens at market cap $324.25B and trailing P/E 20.1.
Not investment advice. Open the AMRN and GS stock pages for the full models.
Not investment advice.